Drug-related problems in head and neck cancer patients identified by repeated medication reviews on consecutive therapy cycles

Breast Cancer

Recent Developments in Metastatic Breast Cancer

healthbook TIMES Oncology Hematology

Head and Neck Cancer

Antibody responses to cancer antigens identify patients with a poor prognosis among HPV-positive and HPV-negative head and neck squamous cell carcinoma patients

Clin Cancer Res.

Laban S, Gangkofner DS, Holzinger D, Schroeder L, Eichmüller SB, Zörnig I, Jäger D, Wichmann G, Dietz A, Broglie MA, Herold-Mende CC, Dyckhoff G, Boscolo-Rizzo P, Ezić J, Marienfeld R, Möller P, Kraus JM, Völkel G, Kestler HA, Brunner C, Schuler PJ, Wigand MC, Theodoraki MN, Doescher J, Hoffmann TK, Pawlita M, Waterboer T, Butt J

doi: 10.1158/1078-0432.CCR-19-1490.

Head and Neck CancerRadio-Oncology

The impact of margin reduction on outcome and toxicity in head and neck cancer patients treated with image-guided volumetric modulated arc therapy (VMAT)

Radiother Oncol.

Navran A, Heemsbergen W, Janssen T, Hamming-Vrieze O, Jonker M, Zuur C, Verheij M, Remeijer P, Sonke JJ, van den Brekel M, Al-Mamgani A

doi: 10.1016/j.radonc.2018.06.032.

Head and Neck Cancer

Clinical outcomes and prognostic factors in recurrent and/or metastatic head and neck cancer patients treated with chemotherapy plus cetuximab as first-line therapy in a real-world setting

Eur J Cancer.

Depenni R, Cossu Rocca M, Ferrari D, Azzarello G, Baldessari C, Alù M, Nolé F, Codecà C, Boscolo G, Piccininni M, Cavalieri S, Bossi P

doi: 10.1016/j.ejca.2019.03.022.

RECOMMENDED

Head and Neck Cancer

Surgical quality assurance in head and neck cancer trials: an EORTC Head and Neck Cancer Group position paper based on the EORTC 1420 'Best of' and 24954 'larynx preservation' study

Eur J Cancer.

Simon C, Caballero C, Gregoire V, Thurnher D, Koivunen P, Ceruse P, Spriano G, Nicolai P, Licitra L, Machiels JP, Hamoir M, Andry G, Mehanna H, Hunter KD, Dietz A, René Leemans C

doi: 10.1016/j.ejca.2018.07.140.

Skin Cancer

Risk of treatment-related mortality in cancer patients treated with ipilimumab: A systematic review and meta-analysis

Eur J Cancer.

Zhang S, Liang F, Li W, Wang Q

doi: 10.1016/j.ejca.2017.06.021.

RECOMMENDED

Head and Neck Cancer

Priorities, concerns, and regret among patients with head and neck cancer

Cancer.

Windon MJ, D'Souza G, Faraji F, Troy T, Koch WM, Gourin CG, Kiess AP, Pitman KT, Eisele DW, Fakhry C

doi: 10.1002/cncr.31920.

Head and Neck Cancer

Combined high-intensity local treatment and systemic therapy in metastatic head and neck squamous cell carcinoma: An analysis of the National Cancer Data Base

Cancer.

Zumsteg ZS, Luu M, Yoshida EJ, Kim S, Tighiouart M, David JM, Shiao SL, Mita AC, Scher KS, Sherman EJ, Lee NY, Ho AS

doi: 10.1002/cncr.30933.

Head and Neck Cancer

Management of elderly patients with locoregionally confined head and neck cancer

Lancet Oncol.

Porceddu SV, Haddad RI

doi: 10.1016/

Related content

Recent Developments in Metastatic Breast Cancer

Antibody responses to cancer antigens identify patients with a poor prognosis among HPV-positive and HPV-negative head and neck squamous cell carcinoma patients

The impact of margin reduction on outcome and toxicity in head and neck cancer patients treated with image-guided volumetric modulated arc therapy (VMAT)

Clinical outcomes and prognostic factors in recurrent and/or metastatic head and neck cancer patients treated with chemotherapy plus cetuximab as first-line therapy in a real-world setting

Surgical quality assurance in head and neck cancer trials: an EORTC Head and Neck Cancer Group position paper based on the EORTC 1420 'Best of' and 24954 'larynx preservation' study

Risk of treatment-related mortality in cancer patients treated with ipilimumab: A systematic review and meta-analysis

Priorities, concerns, and regret among patients with head and neck cancer

Combined high-intensity local treatment and systemic therapy in metastatic head and neck squamous cell carcinoma: An analysis of the National Cancer Data Base

Management of elderly patients with locoregionally confined head and neck cancer